Please assess the completion status of the following clinical trial:

Trial Title: Effects of Octanoic Acid for Treatment of Essential Voice Tremor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants have a diagnosis of essential voice tremor and show signs of tremor during the endoscopy examination (when pictures of the voice box are obtained)during screening appointment~* Participants show measurable voice tremor from recordings of the voice during screening appointment~Exclusion Criteria:~* Participants have a diagnosis or show signs of Parkinson's Disease or another non-essential tremor movement disorder~* Participants have a diagnosis or show signs of spasmodic dysphonia (a different neurological voice disorder)~* Participants have a diagnosis of a severe, non-stable medical condition, such as kidney or liver failure, severe heart disease, severe lung disease, severe metabolic disease, uncontrolled hyperthyroidism, or other life-threatening disease such as active cancer~* Participants have a diagnosis of diabetes mellitus~* Participants are unable to suspend/stop a medication that they are currently taking for tremor or voice disorder for 12 weeks to complete this study~* Participants have a dependence on alcohol or allergy to alcohol~* Participants are pregnant or lactating~* Participants have an allergy to soy~* Participants have Irritable Bowel Syndrome

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Inactive capsule (Type: PLACEBO_COMPARATOR): Participants will receive a pill/capsule with an inactive ingredient during the placebo arm of this study.
- Octanoic acid (Type: EXPERIMENTAL): Participants will receive a pill/capsule with octanoic acid (amount determined by the participant's weight) during the experimental arm of this study.

Based on this trial design, predict the completion outcome and termination type (if applicable).